BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$665M |
| 2 |
Apple
AAPL
|
+$408M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$402M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$223M |
| 5 |
NVIDIA
NVDA
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.87B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$970M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$389M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$350M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.77% |
| 2 | Consumer Discretionary | 6.67% |
| 3 | Healthcare | 6.55% |
| 4 | Financials | 6.32% |
| 5 | Communication Services | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
UroGen Pharma
URGN
$2.4B
| $62.1K | ﹤0.01% |
7,580
+5,881
| +346% | +$40.4K |
|
|
RSX
3327
DELISTED
VanEck Russia ETF
RSX
| $61.5K | ﹤0.01% |
10,888
| – | – |
|
3328
Duluth Holdings
DLTH
$155M
| $61.3K | ﹤0.01% |
6,422
+4,742
| +282% | +$55.1K |
|
|
PRTK
3329
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $60.8K | ﹤0.01% |
31,480
-9,444
| -23% | -$20.6K |
|
3330
Alico
ALCO
$307M
| $60.6K | ﹤0.01% |
1,700
+1,594
| +1,504% | +$63.5K |
|
3331
Gladstone Capital
GLAD
$449M
| $60.3K | ﹤0.01% |
2,988
+838
| +39% | +$19K |
|
3332
OraSure Technologies
OSUR
$265M
| $60.1K | ﹤0.01% |
22,169
-1,045
| -5% | -$5.2K |
|
3333
Aspen Aerogels
ASPN
$509M
| $60K | ﹤0.01% |
6,068
+4,072
| +204% | +$82.2K |
|
|
PZN
3334
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $59.4K | ﹤0.01% |
9,008
+3,518
| +64% | +$23.9K |
|
3335
Rocky Brands
RCKY
$353M
| $59.3K | ﹤0.01% |
1,736
-185
| -10% | -$6.92K |
|
3336
Kodak
KODK
$980M
| $59.2K | ﹤0.01% |
12,757
-9,912
| -44% | -$51.7K |
|
3337
iRadimed
IRMD
$1.12B
| $59.2K | ﹤0.01% |
1,744
-1,507
| -46% | -$54K |
|
3338
Pure Cycle
PCYO
$277M
| $59.2K | ﹤0.01% |
5,615
+2,798
| +99% | +$30.2K |
|
3339
OR Royalties Inc
OR
$6.16B
| $59.2K | ﹤0.01% |
5,859
| – | – |
|
|
LBC
3340
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $59K | ﹤0.01% |
4,521
-262
| -5% | -$3.48K |
|
|
EIGR
3341
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $58.6K | ﹤0.01% |
310
+209
| +207% | +$42.1K |
|
|
KALV
3342
DELISTED
KalVista Pharmaceuticals
KALV
| $58.6K | ﹤0.01% |
5,958
+4,189
| +237% | +$46.2K |
|
3343
FVCBankcorp
FVCB
$340M
| $58.6K | ﹤0.01% |
3,889
+3,730
| +2,346% | +$59.7K |
|
|
PTR
3344
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $58.3K | ﹤0.01% |
1,250
-1,366
| -52% | -$68.9K |
|
3345
MeiraGTx Holdings
MGTX
$1.28B
| $57.3K | ﹤0.01% |
7,568
+3,319
| +78% | +$32.2K |
|
|
CYBE
3346
DELISTED
Cyberoptics Corp
CYBE
| $57K | ﹤0.01% |
1,631
+1,610
| +7,667% | +$65.9K |
|
|
SPLP
3347
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
| $56.6K | ﹤0.01% |
1,349
-1,594
| -54% | -$67.2K |
|
|
PCSB
3348
DELISTED
PCSB Financial Corporation
PCSB
| $56.6K | ﹤0.01% |
2,965
+753
| +34% | +$14.2K |
|
3349
Identive
INVE
$63.6M
| $56.5K | ﹤0.01% |
4,879
+2,988
| +158% | +$37.4K |
|
|
GBL
3350
DELISTED
GAMCO Investors, Inc.
GBL
| $56.4K | ﹤0.01% |
2,700
+2,261
| +515% | +$46.7K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2022 Portfolio in Review
As of Q2 2022, BNP Paribas Financial Markets held 4,360 positions worth $64.1B, down 14% from $74.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets's Q2 2022 filing shows 217 new, 1,899 increased, 1,581 reduced and 272 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M. The largest sale was Invesco QQQ Trust, an estimated $1.87B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- BNP Paribas Financial Markets's largest Q2 2022 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M.
- BNP Paribas Financial Markets added most to Microsoft in Q2 2022, an estimated $665M increase.
- BNP Paribas Financial Markets's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.87B.
- BNP Paribas Financial Markets fully exited Warner Bros in Q2 2022, selling an estimated $27.5M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $64.1B portfolio in Q2 2022.
- BNP Paribas Financial Markets opened 217 new positions and closed 272 in Q2 2022.
- BNP Paribas Financial Markets's portfolio value fell 14% quarter-over-quarter to $64.1B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2022, filed 12 Aug 2022.